Your search for 赛升药业 2026年2月14日 机构观点 压力位 1194 支撑位 1077 全文 resulted in 35 hits
Governance
HSAG has a governing board that oversees policy and direction for our Medicare Quality Innovation Network-Quality Improvement Organization (QIN-QIO). Our Board of Directors has been assembled in accordance with Centers for Medicare & Medicaid Services (CMS) regulations and...
https://www.hsag.com/en/about/what-we-do-services/governance/Model Development Summary
The Anticoagulant-Related Bleeding Risk Prediction Model was developed using 2016–2018 Medicare fee-for-service claims data. To be included in the study cohort, a Medicare beneficiary had to be over 18 years of age, have at least 13 months of continuous enrollment in Parts A/B/D and no Part...
https://www.hsag.com/en/healthcare-policy-quality-measurement/anticoagulant-related-bleeding-prediction-model/model-development-summary/Medicaid External Quality Review
Health Services Advisory Group (HSAG) is the largest External Quality Review Organization (EQRO) in the nation and provides quality review services for states that operate Medicaid managed care programs and fee-for-service programs. As an EQRO, HSAG evaluates managed care organizations (MCOs),...
https://www.hsag.com/program/medicaid-external-quality-review/Section 508 Compliance Statement
HSAG Accessibility Conformance Report The purpose of this report is to assist you in making preliminary assessments regarding HSAG products and services with features that support accessibility. The first table of the report provides a summary view of each of the compliance standards and links to...
https://www.hsag.com/en/section-508-compliance-statement/